-
Diverse Myeloma Treatment Options Through Clinical Trials
Explore how clinical trials are creating more personalized, effective treatment options for people with multiple myeloma in this discussion with Dr. Ajai Chari (UC San Francisco) and patient advocate Bryon Daily (The Leukemia & Lymphoma Society).
-
Small Changes, Big Impact: Easing Myeloma Treatment Side Effects
Small Changes, Big Impact: Easing Myeloma Treatment Side Effects Hear from multiple myeloma advocate Valarie Traynham and leading experts from Mount Sinai as they share practical strategies for handling side effects, optimizing nutrition, and improving quality of life.
-
Tim’s Multiple Myeloma Story
Tim H., Multiple Myeloma Symptoms: None that could be identified; cancer found through CT scan for gallbladder removal Treatments: Chemotherapy, stem cell transplant
-
Julie’s High-Risk Multiple Myeloma Story
Julie C. Symptoms: Queasiness, food aversions, lack of appetite, fatigueTreatment: Stem cell transplant, chemotherapy (D+PD), bispecific antibodies (talquetamab & cevostamab)
-
Relapsed/Refractory Multiple Myeloma Highlights from ASH 2022
Relapsed/Refractory Multiple Myeloma Highlights from ASH 2022 Multiple myeloma specialists Dr. Ajai Chari with Mount Sinai in New York and Dr. Sandy Wong with the University of California San Francisco discuss the big buzz at this year’s ASH: bispecific antibodies.
-
Multiple Myeloma in 2023
Multiple Myeloma in 2023 Long-time myeloma patient and advocate, Jack Aiello, leads the conversation with Dr. Joshua Richter, Multiple Myeloma Director for Blavatnik Family Chelsea Medical Center at Mount Sinai and Dr. Muhamed Baljević, Plasma Cell Disorders Research Director for Vanderbilt-Ingram Cancer Center.
-
Valarie’s Multiple Myeloma Story
Valarie T. Symptoms: Nose bleeds, fatigue, back painTreatment: Chemotherapy, stem cell transplant
-
The Doctor Talk: Latest Relapsed Refractory Multiple Myeloma Treatments
The Doctor Talk w/ Dr. Gasparetto & Dr. Richter Role: Dr. Cristina Gasparetto (Duke) and Dr. Joshua Richter Mount Sinai discuss latest relapsed refractory multiple myeloma treatments
-
Targeted Cancer Therapies
Targeted Cancer Therapies Targeted therapy is a type of cancer treatment also known as precision medicine and molecularly-targeted drugs/therapies. There’s been growing focus on targeted therapy as a major part of precision medicine, which diagnoses and treats individuals based largely on their genes and proteins. It can also be used to prevent disease. This type…
-
Donna’s Multiple Myeloma Story
Donna K., Refractory Multiple Myeloma Symptom: None; found through blood testsTreatments: Total Therapy Four, carfilzomib + pomalidomide, daratumumab + lenalidomide, CAR T-cell therapy, selinexor-carfilzomib
